|Videos|August 19, 2022
The Changing Landscape of Digital Trials
Author(s)Veeva Systems
Richard Young, Vice President of Strategy, Vault CDMS and Tim Davis, Vice President of Strategy, MyVeeva for Patients, discuss the future of digital trials and their impact in the industry.
Advertisement
- It is important to not get caught up on the terminology involved in the new landscape for clinical trials; digital is the how while decentralized is where a trial is done.
- The patient experience within digital trials can be improved by streamlining information and access into a single application.
- Veeva takes an end-to-end approach with clinical trials so patients can participate in them, while taking into consideration their routines and lifestyles.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Redefining Obesity Success in the GLP-1 Era: Q&A with Brian Hilberdink
2
FDA Advisory Committee Votes Unanimously in Favor of the Benefit-Risk Profile of mRNA-1010
3
Additive Manufacturing's Application in Pharma and Biotech
4
Pharma Funding Roudup: Kardigan Announces $400 Million Initial IPO, cAMPfield Launches with $180 million Series A
5